What we do

We're developing a library of early-stage drug assets, for license to pharma and biotech partners - at scale

Our goal is to industrialize early-stage drug discovery: what we call "High Throughput Discovery"

How we do it

Find.Bio runs massive computer simulations of biology at the molecular level (billions of molecules), to uncover the mechanisms of disease and the function of molecules.

Insights from these simulations enable us to provide validated lead drug candidates with far less lab work than industry standard - which means we can produce higher quality molecular assets faster, and at substantially lower cost, than typical approaches.

Drug Discovery at the speed of digital

Learn more about structural biology

How it works

The heart of our platform is a best-in-class, structure-based, AI-powered screening engine. We run this on a global distributed computing network of ~500K CPU cores (*built and operated by our team).

Who we are

Our team has deep experience in drug design, machine learning, molecular modeling, pharmacology, high-throughput computing, and collaboration.

Contact Us

Feel free to contact us with any queries and we will get back to you as soon as possible.

Please note all fields are required.